1. Home
  2. MLYS vs HLX Comparison

MLYS vs HLX Comparison

Compare MLYS & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • HLX
  • Stock Information
  • Founded
  • MLYS 2019
  • HLX 1979
  • Country
  • MLYS United States
  • HLX United States
  • Employees
  • MLYS N/A
  • HLX N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • HLX Oilfield Services/Equipment
  • Sector
  • MLYS Health Care
  • HLX Energy
  • Exchange
  • MLYS Nasdaq
  • HLX Nasdaq
  • Market Cap
  • MLYS 1.0B
  • HLX 931.9M
  • IPO Year
  • MLYS 2023
  • HLX 1997
  • Fundamental
  • Price
  • MLYS $15.58
  • HLX $6.19
  • Analyst Decision
  • MLYS Strong Buy
  • HLX Buy
  • Analyst Count
  • MLYS 3
  • HLX 3
  • Target Price
  • MLYS $33.00
  • HLX $12.50
  • AVG Volume (30 Days)
  • MLYS 866.7K
  • HLX 1.6M
  • Earning Date
  • MLYS 05-12-2025
  • HLX 07-23-2025
  • Dividend Yield
  • MLYS N/A
  • HLX N/A
  • EPS Growth
  • MLYS N/A
  • HLX N/A
  • EPS
  • MLYS N/A
  • HLX 0.55
  • Revenue
  • MLYS N/A
  • HLX $1,340,413,000.00
  • Revenue This Year
  • MLYS N/A
  • HLX N/A
  • Revenue Next Year
  • MLYS N/A
  • HLX $7.01
  • P/E Ratio
  • MLYS N/A
  • HLX $11.32
  • Revenue Growth
  • MLYS N/A
  • HLX 0.34
  • 52 Week Low
  • MLYS $8.24
  • HLX $5.66
  • 52 Week High
  • MLYS $18.38
  • HLX $13.05
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 54.41
  • HLX 40.66
  • Support Level
  • MLYS $15.45
  • HLX $6.36
  • Resistance Level
  • MLYS $16.11
  • HLX $6.43
  • Average True Range (ATR)
  • MLYS 0.96
  • HLX 0.18
  • MACD
  • MLYS -0.05
  • HLX 0.00
  • Stochastic Oscillator
  • MLYS 51.56
  • HLX 15.14

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

Share on Social Networks: